Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct 25;14(21):4490.
doi: 10.3390/nu14214490.

Microbiota Modulation in Patients with Metabolic Syndrome

Ricardo Araujo  1   2 , Marta Borges-Canha  3   4 , Pedro Pimentel-Nunes  4   5
Affiliations
Review

Microbiota Modulation in Patients with Metabolic Syndrome

Ricardo Araujo et al. Nutrients. .

Abstract

Metabolic syndrome (MS) comprises a vast range of metabolic dysfunctions, which can be associated to cardiovascular disease risk factors. MS is reaching pandemic levels worldwide and it currently affects around 25% in the adult population of developed countries. The definition states for the diagnosis of MS may be clear, but it is also relevant to interpret the patient data and realize whether similar criteria were used by different clinicians. The different criteria explain, at least in part, the controversies on the theme. Several studies are presently focusing on the microbiota changes according to the components of MS. It is widely accepted that the gut microbiota is a regulator of metabolic homeostasis, being the gut microbiome in MS described as dysbiotic and certain taxonomic groups associated to metabolic changes. Probiotics, and more recently synbiotics, arise as promising therapeutic alternatives that can mitigate some metabolic disturbances, namely by correcting the microbiome and bringing homeostasis to the gut. The most recent studies were revised and the promising results and perspectives revealed in this review.

Keywords: gut metabolites; gut microbiome; inflammation; metabolic syndrome; obesity; probiotics; synbiotics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Mechanisms and modulation of the relationship between metabolic syndrome, human microbiome, and inflammation.
Figure 2
Figure 2
Diagram with the search results and criteria for selection of sources.
See this image and copyright information in PMC

References

    1. Saklayen M.G. The Global Epidemic of the Metabolic Syndrome. Curr. Hypertens. Rep. 2018;20:12. doi: 10.1007/s11906-018-0812-z. - DOI - PMC - PubMed
    1. Lorenzo C., Williams K., Hunt K.J., Haffner S.M. The National Cholesterol Education Program—Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions of the Metabolic Syndrome as Predictors of Incident Cardiovascular Disease and Diabetes. Diabetes Care. 2007;30:8–13. doi: 10.2337/dc06-1414. - DOI - PubMed
    1. Cornier M.-A., Dabelea D., Hernandez T.L., Lindstrom R.C., Steig A.J., Stob N.R., Van Pelt R.E., Wang H., Eckel R.H. The Metabolic Syndrome. Endocr. Rev. 2008;29:777–822. doi: 10.1210/er.2008-0024. - DOI - PMC - PubMed
    1. McCracken E., Monaghan M., Sreenivasan S. Pathophysiology of the metabolic syndrome. Clin. Dermatol. 2018;36:14–20. doi: 10.1016/j.clindermatol.2017.09.004. - DOI - PubMed
    1. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., Gordon D.J., Krauss R.M., Savage P.J., Smith S.C., Jr., et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112:2735–2752. doi: 10.1161/CIRCULATIONAHA.105.169404. - DOI - PubMed

LinkOut - more resources